These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11184797)

  • 1. Moral hazard in physician prescription behavior.
    Lundin D
    J Health Econ; 2000 Sep; 19(5):639-62. PubMed ID: 11184797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data.
    Crea G; Galizzi MM; Linnosmaa I; Miraldo M
    J Health Econ; 2019 May; 65():153-169. PubMed ID: 31022628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Generic drugs: good or bad? Physician's knowledge of generic drugs and prescribing habits].
    García AJ; Martos F; Leiva F; Sánchez de la Cuesta F
    Gac Sanit; 2003; 17(2):144-9. PubMed ID: 12729542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 5. Hospitals and the generic versus brand-name prescription decision in the outpatient sector.
    Pruckner GJ; Schober T
    Health Econ; 2018 Aug; 27(8):1264-1283. PubMed ID: 29786162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey.
    Kesselheim AS; Gagne JJ; Franklin JM; Eddings W; Fulchino LA; Avorn J; Campbell EG
    J Gen Intern Med; 2016 Jun; 31(6):609-14. PubMed ID: 26883524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician prescribing decisions: the effects of situational involvement and task complexity on information acquisition and decision making.
    Chinburapa V; Larson LN; Brucks M; Draugalis J; Bootman JL; Puto CP
    Soc Sci Med; 1993 Jun; 36(11):1473-82. PubMed ID: 8511635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

  • 9. The importance of the physician in the generic versus trade-name prescription decision.
    Hellerstein JK
    Rand J Econ; 1998; 29(1):108-36. PubMed ID: 10182437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug utilization in primary healthcare centres in the Gaza Strip.
    Ayoub SW; Musalam AH; Abu Mahadi AA
    East Mediterr Health J; 2017 Dec; 23(10):649-656. PubMed ID: 29270964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician and practice characteristics associated with the early utilization of new prescription drugs.
    Tamblyn R; McLeod P; Hanley JA; Girard N; Hurley J
    Med Care; 2003 Aug; 41(8):895-908. PubMed ID: 12886170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing practices of rural primary health care physicians in Uzbekistan.
    Pavin M; Nurgozhin T; Hafner G; Yusufy F; Laing R
    Trop Med Int Health; 2003 Feb; 8(2):182-90. PubMed ID: 12581446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE; Gurwitz JH; Fish LS
    Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
    Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
    Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical decision making in antipsychotic drug choice for schizophrenia.
    Hamann J; Langer B; Leucht S; Busch R; Kissling W
    Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of antibiotics and awareness of antibiotic costs by paediatricians in two hospitals in Greece.
    Maltezou HC; Mougkou K; Iosifidis E; Katerelos P; Roilides E; Theodoridou M
    J Chemother; 2014 Feb; 26(1):26-31. PubMed ID: 24410189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provider and Patient Determinants of Generic Levothyroxine Prescribing: An Electronic Health Records-Based Study.
    Romanelli RJ; Nimbal V; Dutcher SK; Pu X; Segal JB
    Ann Pharmacother; 2017 Aug; 51(8):640-648. PubMed ID: 28425295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The office visit and drug prescription in primary care].
    Gómez-Calcerrada D; Pérez Flores D; Marset P
    Gac Sanit; 1997; 11(2):105-7. PubMed ID: 9378571
    [No Abstract]   [Full Text] [Related]  

  • 20. A population-based study of the use of selective serotonin reuptake inhibitors before and after introduction of generic equivalents.
    Bolton JM; Dahl M; Sareen J; Enns MW; Leslie WD; Collins DM; Alessi-Severini S
    Can J Psychiatry; 2012 Apr; 57(4):223-9. PubMed ID: 22480587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.